Clinical trials
Completed Phase 2 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,297 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 34 |
| 2001 | 32 |
| 2002 | 61 |
| 2003 | 54 |
| 2004 | 73 |
| 2005 | 73 |
| 2006 | 78 |
| 2007 | 80 |
| 2008 | 78 |
| 2009 | 75 |
| 2010 | 66 |
| 2011 | 61 |
| 2012 | 60 |
| 2013 | 55 |
| 2014 | 48 |
| 2015 | 55 |
| 2016 | 45 |
| 2017 | 50 |
| 2018 | 24 |
| 2019 | 23 |
| 2020 | 31 |
| 2021 | 18 |
| 2022 | 16 |
| 2023 | 12 |
| 2024 | 6 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,297 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 70 |
| Eli Lilly and Company | 36 |
| Hoffmann-La Roche | 30 |
| Alliance for Clinical Trials in Oncology | 27 |
| Dana-Farber Cancer Institute | 26 |
| AstraZeneca | 25 |
| Novartis Pharmaceuticals | 24 |
| Memorial Sloan Kettering Cancer Center | 22 |
| SCRI Development Innovations, LLC | 22 |
| Pfizer | 20 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 1,297 |
| Neoplasm Metastasis | 76 |
| Breast Neoplasms, Male | 70 |
| Neoplasms | 61 |
| Triple Negative Breast Neoplasms | 54 |
| Ovarian Neoplasms | 28 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Brain Neoplasms | 25 |
| Lung Neoplasms | 25 |
| Inflammatory Breast Neoplasms | 24 |
Trials
Showing 1 to 25 of 1,297. Each trial links to its page on Pharma Observatory.
1,197 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.